01 11Lyrica
02 1Lyrica EH
03 2Lyrica Eh
04 1Lyrica GEP
05 1Lyrica GIP
06 1Lyrica IH
07 2Lyrica Ih
08 4Total Lyrica
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 3,321
2018 Revenue in Millions : 4,970
Growth (%) : -33
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 255
2019 Revenue in Millions : 273
Growth (%) : -7
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 47
2020 Revenue in Millions : 245
Growth (%) : -79
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 8
2021 Revenue in Millions : 47
Growth (%) : -82
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 624
2021 Revenue in Millions : 729
Growth (%) : -14
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 557
2022 Revenue in Millions : 624
Growth (%) : -11
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 253
2016 Revenue in Millions : 233
Growth (%) : 9
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 248
2017 Revenue in Millions : 238
Growth (%) : 5%
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 268
2018 Revenue in Millions : 257
Growth (%) : 4
Main Therapeutic Indication : Neuroscience/Mental Health
Currency : USD
2014 Revenue in Millions : 12.50%
2013 Revenue in Millions :
Growth (%) :
LOOKING FOR A SUPPLIER?